These effects, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assist the principle of focusing on ACKR3 as a unique technique to modulate the opioid technique, which could open up new therapeutic avenues for opioid-associated disorders. These effects suggest that https://hilaryi516hnf5.loginblogin.com/profile